Glenmark to conduct trials in India for potential COVID-19 drug
Go back to Glenmark to conduct trials in India for potential COVID-19 drug| Gilead Sciences (NASDAQ: GILD) | Delayed: 150.11 -0.78 (0.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $150.89 | 52 Week High | $108.63 | |||
| Open | $150.56 | 52 Week Low | $71.39 | |||
| Day High | $153.23 | P/E | 82.93 | |||
| Day Low | $149.57 | EPS | $1.81 | |||
| Volume | 16,453,710 | |||||
| Baltimore Gas & Electric Company 6.70% Preferred Stock, 1993 Series (AMEX: GLEN) | Delayed: 0.00 -100 (100%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $100.00 | 52 Week High | $100.00 | |||
| Open | $100.00 | 52 Week Low | $100.00 | |||
| Day High | $100.00 | P/E | N/A | |||
| Day Low | $100.00 | EPS | $0.00 | |||
| Volume | 0 | |||||
| (AMEX: SRID) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $ | |||
| Open | $0.00 | 52 Week Low | $ | |||
| Day High | $0.00 | P/E | N/A | |||
| Day Low | $0.00 | EPS | $ | |||
| Volume | 0 | |||||
